| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $55.6M | -11.1% |
| SG&A Expense | $27.3M | -36.5% |
| Operating Income | -$83.0M | +21.5% |
| Net Income | -$82.5M | +21.9% |
| EPS (Basic) | -$2.18 | +47.1% |
| EPS (Diluted) | -$2.18 | +47.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.7M | -69.1% |
| Short-term Investments | $13.9M | -48.3% |
| Current Assets | $37.3M | -57.8% |
| Total Assets | $38.4M | -57.3% |
| Current Liabilities | $33.4M | +26.3% |
| Total Liabilities | $34.3M | +25.4% |
| Stockholders' Equity | $4.1M | -93.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.1M | +13.9% |
| Investing Cash Flow | $13.2M | +5.9% |
| Financing Cash Flow | $27.7M | -62.9% |